SEB Asset Management AB »

Vertex Pharmaceuticals Incorporated shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $63M 141k 446.54

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Wellington Management Company
Victory Capital Management
Ubs Global Asset Management Americas
Jennison Associates

View all funds holding Vertex Pharmaceuticals Incorporated